tiprankstipranks
Sandoz price target raised to CHF 42 from CHF 40 at RBC Capital
PremiumThe FlySandoz price target raised to CHF 42 from CHF 40 at RBC Capital
2M ago
Sandoz price target raised to CHF 35 from CHF 32 at Morgan Stanley
Premium
The Fly
Sandoz price target raised to CHF 35 from CHF 32 at Morgan Stanley
2M ago
Sandoz price target raised to CHF 43 from CHF 36.50 at JPMorgan
Premium
The Fly
Sandoz price target raised to CHF 43 from CHF 36.50 at JPMorgan
2M ago
Axsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz
PremiumThe FlyAxsome Therapeutics reaches agreement to dismiss patent litigation with Sandoz
4M ago
Sandoz Canada announces launch of Jubbonti, Wyost
Premium
The Fly
Sandoz Canada announces launch of Jubbonti, Wyost
4M ago
Sandoz receives FDA approval for Enzeevu
Premium
The Fly
Sandoz receives FDA approval for Enzeevu
4M ago
Sandoz announces FDA approval of biosimilar Pyzchiva
PremiumThe FlySandoz announces FDA approval of biosimilar Pyzchiva
6M ago
Sandoz Canada announces launch of lisdexamfetamine
Premium
The Fly
Sandoz Canada announces launch of lisdexamfetamine
7M ago
Sandoz receives EC approval for Wyost, Jubbonti in Europe
Premium
The Fly
Sandoz receives EC approval for Wyost, Jubbonti in Europe
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100